MyFinsight
Home
About
Contact
medp: the income statement
Download
Download image
Antiviral And Anti
Infective
$36,517K
Cardiology
$59,470K
(6.55%↑ Y/Y)
Central Nervous System
$65,627K
Other
$106,398K
(-0.91%↓ Y/Y)
Metabolic
$199,256K
(59.75%↑ Y/Y)
Oncology
$192,635K
(16.81%↑ Y/Y)
Interest income, net
$1,517K
(-79.85%↓ Y/Y)
Revenue, net (includes
12.2 million and 15.5...
$659,903K
(23.74%↑ Y/Y)
Total other income,
net
$1,028K
(-84.19%↓ Y/Y)
Income from operations
$141,808K
(26.31%↑ Y/Y)
Miscellaneous (expense)
income, net
-$489K
(52.29%↑ Y/Y)
Total operating
expenses
$518,095K
(23.05%↑ Y/Y)
Income before income
taxes
$142,836K
(20.26%↑ Y/Y)
Amortization
$236K
(-34.44%↓ Y/Y)
Depreciation
$6,813K
(-4.82%↓ Y/Y)
Selling, general and
administrative
$48,082K
(-2.31%↓ Y/Y)
Total direct costs
$462,964K
(27.08%↑ Y/Y)
Net income
$111,135K
(15.25%↑ Y/Y)
Income tax provision
$31,701K
(41.84%↑ Y/Y)
Reimbursable Out Of Pocket
Costs
$276,629K
Direct Costs
$186,335K
Back
Back
Income Statement
source: myfinsight.com
Medpace Holdings, Inc. (MEDP)
Medpace Holdings, Inc. (MEDP)